Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Serum soluble mesothelin-related peptide (SMRP): a potential diagnostic and monitoring marker for epithelial ovarian cancer.

Wu X, Li D, Liu L, Liu B, Liang H, Yang B.

Arch Gynecol Obstet. 2014 Jun;289(6):1309-14. doi: 10.1007/s00404-013-3128-x. Epub 2013 Dec 27.

PMID:
24370956
[PubMed - indexed for MEDLINE]
2.

Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis.

Bandiera E, Zanotti L, Fabricio AS, Bucca E, Squarcina E, Romani C, Tassi R, Bignotti E, Todeschini P, Tognon G, Romagnolo C, Gion M, Sartori E, Maggino T, Pecorelli S, Ravaggi A.

Clin Chem Lab Med. 2013 Sep;51(9):1815-24. doi: 10.1515/cclm-2013-0151.

PMID:
24013103
[PubMed - indexed for MEDLINE]
3.

Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer.

Kristjansdottir B, Levan K, Partheen K, Sundfeldt K.

Gynecol Oncol. 2013 Oct;131(1):52-8. doi: 10.1016/j.ygyno.2013.07.094. Epub 2013 Jul 25.

PMID:
23891789
[PubMed - indexed for MEDLINE]
Free Article
4.

The efficacy of YKL-40 and CA125 as biomarkers for epithelial ovarian cancer.

Zou L, He X, Zhang JW.

Braz J Med Biol Res. 2010 Dec;43(12):1232-8. Epub 2010 Nov 26.

PMID:
21103788
[PubMed - indexed for MEDLINE]
Free Article
5.

Evaluation of serum mesothelin in malignant and benign ovarian masses.

Ibrahim M, Bahaa A, Ibrahim A, El Hakem AA, Abo-El Noor A, El Tohamy U.

Arch Gynecol Obstet. 2014 Jul;290(1):107-13. doi: 10.1007/s00404-014-3147-2. Epub 2014 Jan 21.

PMID:
24445964
[PubMed - indexed for MEDLINE]
6.

Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions.

Pass HI, Wali A, Tang N, Ivanova A, Ivanov S, Harbut M, Carbone M, Allard J.

Ann Thorac Surg. 2008 Jan;85(1):265-72; discussion 272.

PMID:
18154821
[PubMed - indexed for MEDLINE]
7.

Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.

Li F, Tie R, Chang K, Wang F, Deng S, Lu W, Yu L, Chen M.

BMC Cancer. 2012 Jun 19;12:258. doi: 10.1186/1471-2407-12-258.

PMID:
22712526
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.

Baron AT, Boardman CH, Lafky JM, Rademaker A, Liu D, Fishman DA, Podratz KC, Maihle NJ.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):306-18. Erratum in: Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1583.

PMID:
15734951
[PubMed - indexed for MEDLINE]
Free Article
9.

Mesothelin is more useful in pleural effusion than in serum in the diagnosis of pleural mesothelioma.

Ferro P, Canessa PA, Battolla E, Dessanti P, Franceschini MC, Chiaffi L, Morabito A, Fontana V, Pezzi R, Fedeli F, Pistillo MP, Roncella S.

Anticancer Res. 2013 Jun;33(6):2707-13.

PMID:
23749930
[PubMed - indexed for MEDLINE]
10.

Diagnostic and prognostic value of soluble mesothelin-related proteins in patients with malignant pleural mesothelioma in comparison with benign asbestosis and lung cancer.

Schneider J, Hoffmann H, Dienemann H, Herth FJ, Meister M, Muley T.

J Thorac Oncol. 2008 Nov;3(11):1317-24. doi: 10.1097/JTO.0b013e318187491c.

PMID:
18978568
[PubMed - indexed for MEDLINE]
11.

Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response.

Hamed EO, Ahmed H, Sedeek OB, Mohammed AM, Abd-Alla AA, Abdel Ghaffar HM.

Diagn Pathol. 2013 Jan 23;8:11. doi: 10.1186/1746-1596-8-11.

PMID:
23343214
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.

Baron AT, Cora EM, Lafky JM, Boardman CH, Buenafe MC, Rademaker A, Liu D, Fishman DA, Podratz KC, Maihle NJ.

Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):103-13.

PMID:
12582019
[PubMed - indexed for MEDLINE]
Free Article
13.

The utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer.

Barlow TS, Przybylski M, Schilder JM, Moore DH, Look KY.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):496-500.

PMID:
16681717
[PubMed - indexed for MEDLINE]
14.

Preoperative serum CA125 levels do not predict suboptimal cytoreductive surgery in epithelial ovarian cancer.

Arits AH, Stoot JE, Botterweck AA, Roumen FJ, Voogd AC.

Int J Gynecol Cancer. 2008 Jul-Aug;18(4):621-8. Epub 2007 Sep 14.

PMID:
17868339
[PubMed - indexed for MEDLINE]
15.

Performance of biomarkers SMRP, CA125, and CYFRA 21-1 as potential tumor markers for malignant mesothelioma and lung cancer in a cohort of workers formerly exposed to asbestos.

Gube M, Taeger D, Weber DG, Pesch B, Brand P, Johnen G, Müller-Lux A, Gross IM, Wiethege T, Weber A, Raithel HJ, Kraus T, Brüning T.

Arch Toxicol. 2011 Mar;85(3):185-92. doi: 10.1007/s00204-010-0580-2. Epub 2010 Aug 25.

PMID:
20737138
[PubMed - indexed for MEDLINE]
16.

Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors.

Carbotti G, Orengo AM, Mezzanzanica D, Bagnoli M, Brizzolara A, Emionite L, Puppo A, Centurioni MG, Bruzzone M, Marroni P, Rossello A, Canevari S, Ferrini S, Fabbi M.

Int J Cancer. 2013 Jun 1;132(11):2597-605. doi: 10.1002/ijc.27948. Epub 2012 Dec 13.

PMID:
23169448
[PubMed - indexed for MEDLINE]
17.

Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management.

Bandiera E, Romani C, Specchia C, Zanotti L, Galli C, Ruggeri G, Tognon G, Bignotti E, Tassi RA, Odicino F, Caimi L, Sartori E, Santin AD, Pecorelli S, Ravaggi A.

Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2496-506. doi: 10.1158/1055-9965.EPI-11-0635. Epub 2011 Oct 25.

PMID:
22028406
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Vascular endothelial growth factor (VEGF) improves the sensitivity of CA125 for differentiation of epithelial ovarian cancers from ovarian cysts.

Robati M, Ghaderi A, Mehraban M, Shafizad A, Nasrolahi H, Mohammadianpanah M.

Arch Gynecol Obstet. 2013 Oct;288(4):859-65. doi: 10.1007/s00404-013-2819-7. Epub 2013 Apr 7.

PMID:
23564055
[PubMed - indexed for MEDLINE]
19.

Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.

Shah CA, Lowe KA, Paley P, Wallace E, Anderson GL, McIntosh MW, Andersen MR, Scholler N, Bergan LA, Thorpe JD, Urban N, Drescher CW.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1365-72. doi: 10.1158/1055-9965.EPI-08-1034.

PMID:
19423517
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer.

Pearl ML, Zhao Q, Yang J, Dong H, Tulley S, Zhang Q, Golightly M, Zucker S, Chen WT.

Gynecol Oncol. 2014 Sep;134(3):581-90. doi: 10.1016/j.ygyno.2014.06.013. Epub 2014 Jun 24.

PMID:
24972191
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk